Showing results (301-310 of 338) with videos related to

Sort By:
Pageof 34
JAMA Oncology|April 30, 2026
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical TrialMark A Socinski, Rolf Stahel, Dae Ho Lee, et al.
Diabetes Care|August 6, 2026
The Gain-of-Function GLP1R R131Q Variant Preserves β-Cell Function and Enhances Response to GLP-1 Receptor AgonistsHyunsuk Lee, Hannah E Christie, Ji Seon Lee, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 1, 2011
Attitudes of cancer patients, family caregivers, oncologists and members of the general public toward critical interventions at the end of life of terminally ill patientsYoung Ho Yun, Kyung Hee Han, Sohee Park, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 27, 2013
The Understanding of Terminal Cancer and Its Relationship with Attitudes toward End-of-Life Care IssuesJune Koo Lee, Young Ho Yun, Ah Reum An, et al.
American Journal of Hematology|November 6, 2009
Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 casesSung Yong Oh, Won Seog Kim, Seok Jin Kim, et al.
The Journal of Biological Chemistry|June 22, 2011
Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthaseHye-Jun Shin, Young-Ho Park, Sun-Uk Kim, et al.
Cell Metabolism|February 11, 2014
Regulation of hepatic energy metabolism and gluconeogenesis by BADAlfredo Giménez-Cassina, Luisa Garcia-Haro, Cheol Soo Choi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2024
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancerEnriqueta Felip, Giulio Metro, Ross A Soo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trialDong-Wan Kim, Dae Ho Lee, Ji-Youn Han, et al.
BMC Cancer|June 24, 2010
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) studyHo-Young Yhim, Hye Jin Kang, Yoon Hee Choi, et al.
Pageof 34